NY A06987

Requires covered entities participating in the federal 340B drug pricing program to submit annual reports to the Department of Health beginning April 1, 2026

Mandates reporting of 340B drug acquisition costs, payments received from insurers and patients, prescription volumes, and percentage of low-income patients (below 200% federal poverty level) served by sliding fee scales

Requires disclosure of payments made to contract pharmacies, third-party administrators, and other vendors for 340B program-related services, compliance, and administration

Demands reporting on contract pharmacy arrangements, including number of out-of-state pharmacies, prescription distribution between in-state and out-of-state locations, and year-over-year changes in contract pharmacy remuneration

Requires an officer of each covered entity to certify report accuracy, with all reports to be posted on a publicly accessible state website